Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
R&D
Biotech
ADC Therapeutics shutters UK R&D site, lays off 30% of staff
The company is closing a U.K. R&D facility and laying off a third of its global workforce, an effort that is expected to be complete by Sept. 30.
Gabrielle Masson
Jun 12, 2025 3:00pm
GSK snags longtime Sanofi exec to lead vaccine development
Jun 9, 2025 10:45am
BioNTech makes £1B commitment to expand UK research, build HQ
May 20, 2025 11:15am
AbbVie tosses ADARx $335M for siRNA options deal
May 14, 2025 9:00am
Arcturus doubles down on mRNA, axes several early-stage assets
May 13, 2025 1:32pm
Vertex takes $379M hit tied to cancelled islet cell program
May 6, 2025 12:50pm
